Results 121 to 130 of about 19,315 (197)

Diffuse Alveolar Hemorrhage Mimicking Pneumonia in a Patient With Interstitial Lung Disease on Ticagrelor. [PDF]

Cureus
Shahbaz MU, Khalid M, Usman M, Asif MZ, Macbruce D.   +4 more
europepmc   +1 more source

Ticagrelor-Induced False-Negative Serotonin Release Assay in Heparin-Induced Thrombocytopenia With Stent Thrombosis. [PDF]

JACC Case Rep
Jamil Y, Bahniwal RK, Nguyen AH, Howard E, Azad F, Ershler WB, Kennedy JLW.   +6 more
europepmc   +1 more source

Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice. [PDF]

J Cardiovasc Dev Dis
Yadav K, Ahmed SES, Abdelgader M, Khalid R, Veerasamy M, Das A, Bulluck H.   +6 more
europepmc   +1 more source

Single Antiplatelet Therapy With Ticagrelor in Flow-Diversion Treatment of Ruptured Dissecting Cerebral Pseudoaneurysms: A Meta-Analysis. [PDF]

Cureus
Alqahtani SA, AlQahatani S.
europepmc   +1 more source

Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases. [PDF]

Am J Case Rep
Herrmann A, Mai B, Bai Y, Castillo B, Kar B, Klein K, Salas de Armas IA, Salazar E, Tint H, Gregoric ID.   +9 more
europepmc   +1 more source

Low-dose ticagrelor combined with aspirin in the prevention of early neurological deterioration of high-risk non-disabling ischemic cerebrovascular events: a PROBE clinical study. [PDF]

Trials
Wang M, Chen R, Yu X, Gong X, Li X, Ji X, Shen J, Cao H, Pu L.   +8 more
europepmc   +1 more source

Associations of new intracranial haemorrhage, ischaemic stroke and survival with dual antiplatelet therapy regimen or duration after endovascular treatment for ruptured cerebral aneurysm. [PDF]

Stroke Vasc Neurol
Perng PS, Chang Y, Chuang MT, Wong CE, Sun YT, Wang HK, Lee JS, Wang LC, Huang CY.   +8 more
europepmc   +1 more source

Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population? [PDF]

Neurotherapeutics
Nedelcu S.
europepmc   +1 more source

Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary Syndromes. [PDF]

J Cardiovasc Dev Dis
Judge HM, Parker WAE, Storey RF.
europepmc   +1 more source

Real-World Antiplatelet Use and Clinical Outcomes in Patients with Advanced Chronic Kidney Disease Following Acute Coronary Syndrome: A Descriptive Cohort Study. [PDF]

J Clin Med
Alfehaid L, Alzahrani E, Alsubaie A, Almutairi M, Alomran M, Alghadeer S.   +5 more
europepmc   +1 more source